RNS
MNTA

Robert N. Shapiro’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Robert N. Shapiro’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$22K Hold
1,813
– – ﹤0.01% 609
2014
Q3 		$21K Hold
1,813
– – ﹤0.01% 627
2014
Q2 		$22K Hold
1,813
– – ﹤0.01% 581
2014
Q1 		$21K Hold
1,813
– – ﹤0.01% 580
2013
Q4 		$32K Hold
1,813
– – 0.01% 525
2013
Q3 		$26K Hold
1,813
– – ﹤0.01% 745
2013
Q2 		$27K Buy
+1,813
New +$23.9K 0.01% 687

Other funds holding MNTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Robert N. Shapiro's MNTA Position: Q4 2014 in Review

Robert N. Shapiro held its Momenta Pharmaceuticals, Inc. (MNTA) position steady in Q4 2014 at 1,813 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Robert N. Shapiro first reported a position in MNTA in Q2 2013 and has held it in 7 quarters since. The position peaked at $32K in Q4 2013. 148 funds tracked by Wall St. Rank hold MNTA as of Q4 2014.

  • Robert N. Shapiro held 1,813 shares of Momenta Pharmaceuticals, Inc. worth $22K as of Q4 2014.
  • Robert N. Shapiro left its Momenta Pharmaceuticals, Inc. share count unchanged in Q4 2014.
  • Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #609 holding.
  • Robert N. Shapiro first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Momenta Pharmaceuticals, Inc. position peaked at $32K in Q4 2013.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.